Translocations of the RARalpha gene in acute promyelocytic leukemia
- PMID: 11704847
- DOI: 10.1038/sj.onc.1204766
Translocations of the RARalpha gene in acute promyelocytic leukemia
Abstract
Acute promyelocytic leukemia (APL) has been recognized as a distinct clinical entity for over 40 years. Although relatively rare among hematopoietic malignancies (approximately 10% of AML cases), this disease has attracted a particularly good share of attention by becoming the first human cancer in which all-trans-retinoic acid (ATRA), a physiologically active derivative of vitamin A, was able to induce complete remission (CR). ATRA induced remission is not associated with rapid cell death, as in the case of conventional chemotherapy, but with a restoration of the 'normal' granulocytic differentiation pathway. With this remarkable medical success story APL has overnight become a paradigm for the differentiation therapy of cancer. A few years later, excitement with APL was further enhanced by the discovery that a cytogenetic marker for this disease, the t(15:17) reciprocal chromosomal translocation, involves a fusion between the retinoic acid receptor alpha (RARalpha) gene and a previously unknown locus named promyelocytic leukemia (PML). Consequence of this gene rearrangement is expression of the PML-RARalpha chimeric oncoprotein, which is responsible for the cellular transformation as well as ATRA response that is observed in APL. Since this initial discovery, a number of different translocation partner genes of RARalpha have been reported in rarer cases of APL, strongly suggesting that disruption of RARalpha underlies its pathogenesis. This article reviews various rearrangements of the RARalpha gene that have so far been described in literature, functions of the proteins encoded by the different RARalpha partner loci, and implications that these may have for the molecular pathogenesis of APL.
Similar articles
-
Acute promyelocytic leukemia with a STAT5b-RARα fusion transcript defined by array-CGH, FISH, and RT-PCR.Cancer Genet. 2012 Jun;205(6):327-31. doi: 10.1016/j.cancergen.2012.02.007. Cancer Genet. 2012. PMID: 22749039
-
Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha.Proc Natl Acad Sci U S A. 1999 May 25;96(11):6318-23. doi: 10.1073/pnas.96.11.6318. Proc Natl Acad Sci U S A. 1999. PMID: 10339585 Free PMC article.
-
Transcription therapy for acute promyelocytic leukaemia.Expert Opin Investig Drugs. 2000 Feb;9(2):329-46. doi: 10.1517/13543784.9.2.329. Expert Opin Investig Drugs. 2000. PMID: 11060680 Review.
-
Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways.Blood. 2002 Apr 15;99(8):2637-46. doi: 10.1182/blood.v99.8.2637. Blood. 2002. PMID: 11929748
-
Understanding the molecular pathogenesis of acute promyelocytic leukemia.Best Pract Res Clin Haematol. 2014 Mar;27(1):3-9. doi: 10.1016/j.beha.2014.04.006. Epub 2014 Apr 13. Best Pract Res Clin Haematol. 2014. PMID: 24907012 Review.
Cited by
-
Acute Promyelocytic Leukemia with Rare Genetic Aberrations: A Report of Three Cases.Genes (Basel). 2022 Dec 23;14(1):46. doi: 10.3390/genes14010046. Genes (Basel). 2022. PMID: 36672788 Free PMC article.
-
Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion-associated myeloid neoplasm.Blood Adv. 2022 Feb 22;6(4):1137-1142. doi: 10.1182/bloodadvances.2021004966. Blood Adv. 2022. PMID: 34551074 Free PMC article.
-
Molecular testing for acute myeloid leukemia.Cancer Biol Med. 2021 Aug 4;19(1):4-13. doi: 10.20892/j.issn.2095-3941.2020.0734. Online ahead of print. Cancer Biol Med. 2021. PMID: 34347394 Free PMC article. Review.
-
Development of treatment and clinical results in childhood AML in Austria (1993-2013).Memo. 2014;7(1):63-74. doi: 10.1007/s12254-014-0135-y. Epub 2014 Mar 1. Memo. 2014. PMID: 32288851 Free PMC article.
-
Acute Promyelocytic Leukemia: A Constellation of Molecular Events around a Single PML-RARA Fusion Gene.Cancers (Basel). 2020 Mar 8;12(3):624. doi: 10.3390/cancers12030624. Cancers (Basel). 2020. PMID: 32182684 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous